Serge Saxonov - 05 Jan 2026 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Serge Saxonov
Issuer symbol
TXG
Transactions as of
05 Jan 2026
Net transactions value
+$60,000
Form type
4
Filing time
07 Jan 2026, 16:52:55 UTC
Previous filing
25 Nov 2025
Next filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saxonov Serge Chief Executive Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Serge Saxonov 07 Jan 2026 0001786720

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $60,000 +50,000 +4.9% $1.20 1,071,556 05 Jan 2026 Direct
holding TXG Class A Common Stock 27 05 Jan 2026 See footnote F1
holding TXG Class A Common Stock 213,250 05 Jan 2026 See footnote F2
holding TXG Class A Common Stock 58,000 05 Jan 2026 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -17,463 -100% $0.000000 0 05 Jan 2026 Class A Common Stock 17,463 $1.20 Direct F4
transaction TXG Stock Option (right to buy) Options Exercise $0 -32,537 -16% $0.000000 173,600 05 Jan 2026 Class A Common Stock 32,537 $1.20 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F2 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
F4 All of the shares subject to the option are fully vested and exercisable as of the date hereof.